SCHEMBL1242685

SCHEMBL1242685

O=C1C(N2CCCCC2)=C(N2CCCCC2)C(=O)c2ccccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.67
ALDH1A1 P00352 8/20 0.67
APAF1 O14727 6/20 0.67
SMN1; SMN2 Q16637 4/20 0.67
HTT P42858 4/20 0.67
NPC1 O15118 4/20 0.67
LMNA P02545 3/20 0.67
MITF O75030 1/20 0.67
POLB P06746 1/20 0.67
KLF5 Q13887 1/20 0.67
TDP1 Q9NUW8 3/20 0.61
NPSR1 Q6W5P4 2/20 0.61
RAB9A P51151 4/20 0.59
NSD2 O96028 4/20 0.59
TDP2 O95551 3/20 0.59
HKDC1 Q2TB90 1/20 0.59
L3MBTL1 Q9Y468 6/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
GAA P10253 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL245954 0.92 APAF1 (0.61) MAPTALDH1A1APAF1SMN1; SMN2HTT
Hydrochloric Acid SCHEMBL4204888 0.91 APAF1 (0.60) MAPTALDH1A1APAF1SMN1; SMN2HTT
SCHEMBL10446114 0.87 NSD2 (0.71) MAPTALDH1A1APAF1SMN1; SMN2HTT
SCHEMBL8568869 0.84 NSD2 (0.73) MAPTALDH1A1APAF1SMN1; SMN2HTT
SCHEMBL14567092 0.84 ALDH1A1 (0.51) MAPTALDH1A1APAF1SMN1; SMN2HTT
Hydrochloric Acid SCHEMBL4204889 0.83 APAF1 (0.56) MAPTALDH1A1APAF1SMN1; SMN2HTT
SCHEMBL1240472 0.82 MAPT (0.57) MAPTALDH1A1APAF1SMN1; SMN2HTT
SCHEMBL14567099 0.82 ALDH1A1 (0.49) MAPTALDH1A1APAF1SMN1; SMN2HTT
SCHEMBL14788035 0.81 MAPT (0.75) MAPTALDH1A1APAF1SMN1; SMN2HTT
SCHEMBL16297187 0.81 APAF1 (1.00) MAPTALDH1A1APAF1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4324852-A REDOX COUPLES EASTMAN KODAK COMPANY (US) 1982-04-13 US claimed
US-4201588-A NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, CARBAZIDES OR QUINONES AS PHOTOREDUCTANT; EXTERNAL HYDROGEN SOURCE EASTMAN KODAK COMPANY (US) 1980-05-06 US claimed
US-4195998-A NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, QUINONE OR CARBAZIDE PHOTOREDUCTANT EASTMAN KODAK COMPANY (US) 1980-04-01 US claimed
US-10472315-B2 Inhibitors of methionine aminopeptidases and methods of treating disorders THE JOHNS HOPKINS UNIVERSITY (US) 2019-11-12 US disclosed
US-20120196852-A1 INHIBITORS OF METHIONINE AMINOPEPTIDASES AND METHODS OF TREATING DISORDERS THE JOHNS HOPKINS UNIVERSITY (US) 2012-08-02 US disclosed
WO-2011017519-A2 INHIBITORS OF METHIONINE AMINOPEPTIDASES AND METHODS OF TREATING DISORDERS THE JOHNS HOPKINS UNIVERSITY (US) 2011-02-10 WO disclosed
EP-0383536-A2 Thermo-sensitive transfer printing medium SEIKO INSTRUMENTS INC. (JP) 1990-08-22 EP disclosed
US-4332884-A USING A DIOXIME CHELATING AGENT RICOH CO., LTD. (JP) 1982-06-01 US disclosed
US-4315068-A CONTAINING A COBALT-AMMINE COMPLEX AND A DIOXIME OR A BISIMIDAZOLIN-3-ONE CHELATING AGENT; STABILITY; COLOR DILMS RICOH CO., LTD. (JP) 1982-02-09 US disclosed
US-4306014-A AMMONIA OR AMINES SUPPRESS THE COLOR-FORMING REACTION SYSTEM RICOH CO., LTD. (JP) 1981-12-15 US disclosed
US-4201588-A NONSILVER PHOTOGRAPHIC FILMS; DISULFIDE, DIAZOANTHRONE, DIAZOPHENANTHRONE, AROMATIC AZIDE, CARBAZIDES OR QUINONES AS PHOTOREDUCTANT; EXTERNAL HYDROGEN SOURCE EASTMAN KODAK COMPANY (US) 1980-05-06 US disclosed
US-4171221-A NONSILVER PHOTOGTAPHY EASTMAN KODAK COMPANY (US) 1979-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196852-A1 INHIBITORS OF METHIONINE AMINOPEPTIDASES AND METHODS OF TREATING DISORDERS METAP1, METAP2, ENPEP MAPT 1551/4885ALDH1A1 1430/4885APAF1 1900/4885
US-10472315-B2 Inhibitors of methionine aminopeptidases and methods of treating disorders METAP1, METAP2, ENPEP MAPT 1551/4885ALDH1A1 1430/4885APAF1 1900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.